- Taa, Canopy kwupụtara na ọ ga-amalite na nzuzo na $ 13 nde ego iji kwadoo omume oncology nke mba ahụ iji nyere aka na-enye nlekọta dị elu maka ndị ọrịa cancer mgbe ọ na-anọghị n'ụlọ ọrụ dọkịta.
- Ndị mmekọ Canopy na omume oncology na-eduga mba iji wepụta nsonaazụ kacha mma maka ndị ọrịa kansa karịrị 50,000.
Canopy, Palo Alto, California dabeere na oncology intelligent care platform (ICP), mara ọkwa taa na ọ welitere $13 nde na ego nke GSR Ventures na-eduga na nsonye sitere na Samsung Next, UpWest, na ndị isi ụlọ ọrụ na ndị isi ụlọ ọrụ gụnyere Geoff Otu n'ime ha bụ. Calkins (nke bụbu SVP nke ngwaahịa na Flatiron Health) na Chris Mansi (CEO nke Viz.AI) .Canopy, nke a na-akpọbu Expain, na-amalitekwa na nzuzo taa iji mee ka ikpo okwu ya dị n'ozuzu maka ụlọ ọrụ ọgwụgwọ ọrịa cancer n'ofe US.
Kwiatkowsky, bụ onye tọrọ ntọala Canopy na 2018, enweelarị aka na usoro nlekọta ahụike, na-akọwapụta ihe ịma aka ndị dị na nlekọta nkwụsịtụ taa, karịsịa na mpaghara ọrịa mgbagwoju anya dị ka oncology. Site na usoro a, ọ ghọtara na ìgwè ndị nọọsụ na-ejupụta na ya. ozi, ọrụ, na ihe ịma aka, na-amachi ikike ha iji teknụzụ dị mkpa iji meziwanye nlekọta. Ahụmahụ a nyere Canopy isi nghọta: "Iji nyere ndị ọrịa aka, ị ga-ebu ụzọ nyere aka na-eme ihe."Tupu ịmalite Canopy, ọ nọrọ afọ 16 gara aga na ọrụ ọgụgụ isi nke Israel na mgbe e mesịrị na Israel mmalite Na-arụ ọrụ iji duzie nnukwu ọrụ metụtara nhazi data, ọgụgụ isi na mmụta igwe.
N'ihi ọdịdị na-adịru nwa oge na nke episodic nke nlekọta ọrịa cancer na ụlọ ọrụ, ihe ruru 50% nke mgbaàmà ndị ọrịa na mmetụta ọgwụgwọ agaghị achọpụta. Nke a na-ebutekarị nleta ụlọ ọgwụ a na-ezere na ahụmahụ na-adịghị mma, na nke ka mkpa, nkwụsị ọgwụgwọ nwere ike imerụ ahụ. mebie ohere onye ọrịa nwere ịlanarị. Nke a na-akawanye njọ n'oge ọrịa na-efe efe dị ka ndị ọkachamara n'ọrịa oncologists na-adabere na mpempe akwụkwọ, oku ekwentị na usoro akwụkwọ ntuziaka ndị ọzọ na-adịghị mma, dị oke ọnụ na nke na-adịghị mma. Nnyocha na-egosi na nlekota anya nke ndị ọrịa na-enweta ọgwụgwọ ọrịa cancer nwere ike imeziwanye ndụ ndụ, afọ ojuju. , na nlanarị n'ozuzu ya, mana ndị na-enye ya enweghị ngwaọrụ iji wepụta nlekọta dịpụrụ adịpụ na ngwa ngwa.
Canopy revolutionizes ihe nlereanya a site na-enyere ndị dọkịta aka iso ndị ọrịa na-aga n'ihu ma na-arụsi ọrụ ike na-emekọrịta ihe. Canopy's Smart Care Platform gụnyere a sara mbara suite nke nwere ọgụgụ isi, electronic ahụike ndekọ mwekota ngwá ọrụ na-enyere cancer emmepe nọgidere na-emekọ ihe na ndị ọrịa, streamline clinical workflows, na weghara ọhụrụ reimbursement iyi maka. ọrụ ha bara uru. N'ihi ya, ndị otu nlekọta nwere ike gbanwee ihe onwunwe site na ọrụ ntuziaka ugboro ugboro na-akwado ndị ọrịa na-achọkarị ha, na-eme ka nsonaazụ ndị ọrịa dịkwuo ala.
Igwe ikpo okwu Canopy, na mmekorita ya na usoro oncology nke mba, gosipụtara ndebanye aha ndị ọrịa dị elu (86%), ntinye aka (88%), njigide (90% na ọnwa 6) na ọnụego ntinye aka n'oge (88%). Nsonaazụ ụlọ ọgwụ sitere na Canopy, n'ihi na 2022, na-egosi mbelata nke itinye n'ọrụ ngalaba mberede na nnabata ụlọ ọgwụ, yana mmụba nke oge ọgwụgwọ.
Canopy bụ onye na-enye ọkacha mmasị nke Quality Cancer Care Alliance (QCCA) yana ndị mmekọ na-eduga oncology omume n'ofe mba ahụ, gụnyere Highlands Oncology Group, North Florida Cancer Specialties, Northwestern Medicine Specialties, Los Angeles Cancer Network, Western Cancer na Hematology Center Michigan na Ọkachamara Ọrịa Cancer Tennessee (TCS).
Lavi Kwiatkowsky, onye nchoputa na onye isi oche nke Canopy kwuru, "Ọrụ Canopy bụ ịnye nsonaazụ na ahụmịhe kachasị mma maka onye ọ bụla na-anata ọgwụgwọ ọrịa kansa." Anyị egosila na ụlọ ọrụ ọgwụgwọ ọrịa kansa n'ofe US na ụdị nnyefe nlekọta ahụike abụghị naanị enwere ike. , ma dị irè.Ugbu a, anyị lekwasịrị anya n'ịgbasa ọnụnọ mba anyị ka anyị na-ebuga ọgụgụ isi mmadụ, iji bulie uru anyị na-ewetara ndị ọrịa na ndị otu nlekọta ha. "
Akpadoro ya na: ọgụgụ isi, ọgụgụ isi, ọrịa kansa, ndị otu nlekọta, usoro ọgwụgwọ ụlọ ọgwụ, ahụike flatiron, mmụta igwe, ụdị, oncology, mmalite ahụike dijitalụ oncology, nyiwe oncology, ahụmịhe onye ọrịa, ndị dọkịta, samsung
Oge nzipu: Mar-23-2022
